Publications by authors named "Pichai Raman"

Are you Pichai Raman?   Register this Author

Author Correction: The landscape of genomic alterations across childhood cancers.
Nature 2018 Jun 6. Epub 2018 Jun 6.
EMBL Heidelberg, Genome Biology, Heidelberg, Germany.


The landscape of genomic alterations across childhood cancers.
Nature 2018 Mar 28;555(7696):321-327. Epub 2018 Feb 28.
Hopp-Children's Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany.




Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma.
Cancer Cell 2017 Sep;32(3):295-309.e12
Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Colket Translational Research Building, 3501 Civic Center Boulevard, Philadelphia, PA 19104, USA; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address:


Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma.
Clin Cancer Res 2017 Apr 11;23(7):1785-1796. Epub 2016 Oct 11.
Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy.
Cancer Discov 2015 Dec 29;5(12):1282-95. Epub 2015 Oct 29.
Division of Cancer Pathobiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Immunology Graduate Group, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Cell & Molecular Biology Graduate Group, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Department of Pathology & Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Recruitment of Pontin/Reptin by E2f1 amplifies E2f transcriptional response during cancer progression.
Nat Commun 2015 Dec 7;6:10028. Epub 2015 Dec 7.
Division of Cancer Pathobiology, Department of Pathology and Laboratory Medicine, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.

A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis.
Cancer Cell 2015 Nov 17;28(5):599-609. Epub 2015 Oct 17.
Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Abramson Family Cancer Research Institute, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address:

CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus.
Cancer Res 2015 Aug 22;75(15):3155-66. Epub 2015 Jun 22.
Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania. The Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.

Genomic and functional comparison of mesenchymal stromal cells prepared using two isolation methods.
Cytotherapy 2015 Mar;17(3):262-70
Division of Oncology/Blood and Marrow Transplantation, The Children's Hospital of Philadelphia and The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; Center for Childhood Cancer and Blood Diseases, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA; Divsion of Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, Ohio, USA. Electronic address:

Masking epistasis between MYC and TGF-β pathways in antiangiogenesis-mediated colon cancer suppression.
J Natl Cancer Inst 2014 Apr 13;106(4):dju043. Epub 2014 Mar 13.
Affiliations of authors: Division of Cancer Pathobiology, Center for Childhood Cancer Research (MD, GST, SH, AT-T) and Center for Biomedical Informatics (PR), Children's Hospital of Philadelphia, Philadelphia, PA; Cancer Biology Graduate Program (JC, EKD, AT-T) and Department of Pathology & Laboratory Medicine (AT-T), Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Division of Experimental Pathology, Beth Israel Deaconess Medical Center (JL) and Department of Medical Oncology, Dana-Farber Cancer Institute (AB), Harvard Medical School, Boston, MA.






OF